SEC Form 3 · accession 0001125858-15-000002
EASTGATE BIOTECH CORP · ETBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rose C Perri
Officer — President
Period of report
Jan 15, 2015
Accepted (ET)
Jan 26, 2015 · 2:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099574
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 5,395,519 | D | ||
| Common Shares | holding | — | — | — | 10,000,000 | I | owned on record by TGT Insvestment Management Inc. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.25 | holding | — | — | — | Mar 21, 2014 | Mar 21, 2019 | Common Shares | 540,000 | — | D |
| Warrant | $0.25 | holding | — | — | — | Nov 9, 2014 | Nov 9, 2019 | Common Shares | 320,400 | — | D |
| Warrant | $0.04 | holding | — | — | — | Jan 5, 2015 | Jan 5, 2020 | Common Shares | 1,036,475 | — | D |